MedComm最新文献

筛选
英文 中文
Carabrone Attenuates Metabolic Dysfunction–Associated Steatohepatitis by Targeting STAT3 in Mice
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70145
An Pan, Jiaming Jin, Yuze Wu, Qiang Zhang, Huanhuan Chen, Yang Hu, Wen Xiao, Anqi Shi, Yang Yang, Lina Jiang, Minghui Tan, Junwei Wang, Lihong Hu
{"title":"Carabrone Attenuates Metabolic Dysfunction–Associated Steatohepatitis by Targeting STAT3 in Mice","authors":"An Pan,&nbsp;Jiaming Jin,&nbsp;Yuze Wu,&nbsp;Qiang Zhang,&nbsp;Huanhuan Chen,&nbsp;Yang Hu,&nbsp;Wen Xiao,&nbsp;Anqi Shi,&nbsp;Yang Yang,&nbsp;Lina Jiang,&nbsp;Minghui Tan,&nbsp;Junwei Wang,&nbsp;Lihong Hu","doi":"10.1002/mco2.70145","DOIUrl":"https://doi.org/10.1002/mco2.70145","url":null,"abstract":"<p>Metabolic dysfunction–associated steatohepatitis (MASH) has become one of the most common progressive liver diseases worldwide, but effective treatment options are severely unmet. Carabrone, a sesquiterpene lactone from the traditional Chinese herb <i>Carpesium abrotanoides </i>L., shows various pharmacological properties, whereas its effect on the improvement of MASH and the underlying mechanisms have not yet been reported. In this work, we revealed for the first time the beneficial effect of carabrone on MASH, including reducing liver lipid accumulation, inflammatory cell infiltration, and fibrosis in multiple diet-induced mice. Carabrone also alleviated lipid accumulation and inflammation in palmitic acid/oleic acid–stimulated hepatocytes. Mechanically, we identified signal transducers and transcriptional activator 3 (STAT3) as a key target of carabrone for treating MASH through quantitative chemical proteomic analysis, as well as the verification by the overexpression of STAT3 in vivo and in vitro. Further studies demonstrated that carabrone blocks MASH progression by inhibiting the activation of STAT3. More importantly, a new carabrone derivative <b>CA-21</b> with stronger anti-MASH activity and affinity for STAT3 was discovered through rational structural modification. Taken together, our findings suggest that carabrone and <b>CA-21</b> could be developed as promising drug candidates for MASH treatment.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70145","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70126
Jiarun Lai, Shaoyou Liu, Yupeng Chen, Jian Chen, Jinchuang Li, Zhenguo Liang, Xinyue Mei, Yuanfa Feng, Zhaodong Han, Funeng Jiang, Shengbang Yang, Yongding Wu, Huijing Tan, Junchen Liu, Huichan He, Weide Zhong
{"title":"Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway","authors":"Jiarun Lai,&nbsp;Shaoyou Liu,&nbsp;Yupeng Chen,&nbsp;Jian Chen,&nbsp;Jinchuang Li,&nbsp;Zhenguo Liang,&nbsp;Xinyue Mei,&nbsp;Yuanfa Feng,&nbsp;Zhaodong Han,&nbsp;Funeng Jiang,&nbsp;Shengbang Yang,&nbsp;Yongding Wu,&nbsp;Huijing Tan,&nbsp;Junchen Liu,&nbsp;Huichan He,&nbsp;Weide Zhong","doi":"10.1002/mco2.70126","DOIUrl":"https://doi.org/10.1002/mco2.70126","url":null,"abstract":"<p>Hyperactivation of fatty acid biosynthesis holds promise as a targeted therapeutic strategy in prostate cancer (PCa). However, inhibiting these enzymes could potentially promote metastatic progression in various other cancers. Herein, we found that depletion of acetyl-CoA carboxylase 1 (encoded by ACACA), the enzyme responsible for the first and rate-limiting step of de novo fatty acid biosynthesis, facilitated epithelial-mesenchymal transition (EMT) and migration of PCa cells. This finding was validated in vitro through cell migration assays and in vivo using a metastatic model established by tail vein injection of ACACA-depleted cells into BALB/c nude mice. Additionally, depletion of ACACA activated the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated protein kinases (ERK) pathway. Inhibition of the MAPK/ERK signaling pathway reduced EMT and migration in ACACA-depleted cells. Our study is the first to indicate targeting ACACA induces an “unexpected” escape program through activation of the MAPK/ERK signaling pathway in PCa, ultimately leading to EMT and metastasis. Therefore, we strongly recommend that the potential adverse effects of targeting ACACA or its derived therapeutic agents must be given extreme attention, especially in MAPK-related cancers.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70126","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNA Modification in Metabolism
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70135
Yadi Liu, Zhongyan Sun, Dingkun Gui, Yonghua Zhao, Youhua Xu
{"title":"RNA Modification in Metabolism","authors":"Yadi Liu,&nbsp;Zhongyan Sun,&nbsp;Dingkun Gui,&nbsp;Yonghua Zhao,&nbsp;Youhua Xu","doi":"10.1002/mco2.70135","DOIUrl":"https://doi.org/10.1002/mco2.70135","url":null,"abstract":"<p>Epigenetic regulation in disease development has been witnessed within this decade. RNA methylation is the predominant form of epigenetic regulation, and the most prevalent modification in RNA is N6-methyladenosine (m<sup>6</sup>A). Recently, RNA modification has emerged as a potential target for disease treatment. RNA modification is a posttranscriptional gene expression regulation that is involved in both physiological and pathological processes. Evidence suggests that m<sup>6</sup>A methylation significantly affects RNA metabolism, and its abnormal changes have been observed in a variety of diseases. Metabolic diseases are a series of diseases caused by abnormal metabolic processes of the body, the common metabolic diseases include diabetes mellitus, obesity, and nonalcoholic fatty liver disease, etc.; although the pathogenesis of these diseases differs from each other to the current understanding, most recent studies suggested pivotal role m<sup>6</sup>A in modulating these metabolic diseases, and m<sup>6</sup>A-based drug development has been on the agenda. This paper reviewed recent understanding of RNA modification in metabolic diseases, hoping to provide systematic information for those in this area.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70135","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70128
Bing Zhong, Jintao Du, Feng Liu, Silu Sun
{"title":"The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer","authors":"Bing Zhong,&nbsp;Jintao Du,&nbsp;Feng Liu,&nbsp;Silu Sun","doi":"10.1002/mco2.70128","DOIUrl":"https://doi.org/10.1002/mco2.70128","url":null,"abstract":"<p>Yes-associated protein (YAP) plays a central role in the Hippo pathway, primarily governing cell proliferation, differentiation, and apoptosis. Its significance extends to tumorigenesis and inflammatory conditions, impacting disease initiation and progression. Given the increasing relevance of YAP in inflammatory disorders and cancer, this study aims to elucidate its pathological regulatory functions in these contexts. Specifically, we aim to investigate the involvement and molecular mechanisms of YAP in various inflammatory diseases and cancers. We particularly focus on how YAP activation, whether through Hippo-dependent or independent pathways, triggers the release of inflammation and inflammatory mediators in respiratory, cardiovascular, and digestive inflammatory conditions. In cancer, YAP not only promotes tumor cell proliferation and differentiation but also modulates the tumor immune microenvironment, thereby fostering tumor metastasis and progression. Additionally, we provide an overview of current YAP-targeted therapies. By emphasizing YAP's role in inflammatory diseases and cancer, this study aims to enhance our understanding of the protein's pivotal involvement in disease processes, elucidate the intricate pathological mechanisms of related diseases, and contribute to future drug development strategies targeting YAP.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70128","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK/JNK Pathway in Hyperplastic Prostate
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70129
Huan Liu, Yongying Zhou, Zhen Wang, Daoquan Liu, Yan Li, Huan Lai, Jizhang Qiu, Shidong Shan, Feng Guo, Ping Chen, Yuming Guo, Guang Zeng, Michael E. DiSanto, Xinhua Zhang
{"title":"Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK/JNK Pathway in Hyperplastic Prostate","authors":"Huan Liu,&nbsp;Yongying Zhou,&nbsp;Zhen Wang,&nbsp;Daoquan Liu,&nbsp;Yan Li,&nbsp;Huan Lai,&nbsp;Jizhang Qiu,&nbsp;Shidong Shan,&nbsp;Feng Guo,&nbsp;Ping Chen,&nbsp;Yuming Guo,&nbsp;Guang Zeng,&nbsp;Michael E. DiSanto,&nbsp;Xinhua Zhang","doi":"10.1002/mco2.70129","DOIUrl":"https://doi.org/10.1002/mco2.70129","url":null,"abstract":"<p>Benign prostatic hyperplasia (BPH) is a prevalent disorder in aging males. It is investigated whether heat shock protein family A member 1A (HSPA1A), a cytoprotective chaperone induced under stress, has been implicated in the development of BPH. RNA-sequencing and single-cell sequencing analyses revealed significant upregulation of HSPA1A in BPH compared to controls. In vitro experiments elucidated that HSPA1A was localized in prostatic epithelium and stroma, with upregulated expression in BPH tissues. Moreover, HSPA1A silencing augmented apoptosis and reactive oxygen species (ROS) accumulation, inhibiting proliferation via ERK/JNK activation, while overexpression reversed these effects in prostatic BPH-1 and WPMY-1 cells. Additionally, ERK1/2 suppression with U0126 rescued the effects of HSPA1A silencing. In vivo, testosterone-induced BPH (T-BPH) rat models treated with the HSPA1A antagonist KNK437 exhibited prostatic atrophy and molecular changes consistent with reduced HSPA1A activity. Finally, we conducted a tissue microarray (TMA) analysis of 139 BPH specimens from Zhongnan Hospital of Wuhan University, which revealed a positive correlation between HSPA1A expression and clinical parameters, including prostate volume (PV), tPSA, fPSA, and IPSS. In conclusion, our findings suggested that HSPA1A attenuated apoptosis and oxidative stress through the ERK/JNK signaling pathway, contributing to BPH pathogenesis.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70129","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep Disorders: Pathogenesis and Therapeutic Interventions
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70130
Cheng Liu, Zhigang He, Yanqiong Wu, Yanbo Liu, Zhixiao Li, Yifan Jia, Hongbing Xiang
{"title":"Sleep Disorders: Pathogenesis and Therapeutic Interventions","authors":"Cheng Liu,&nbsp;Zhigang He,&nbsp;Yanqiong Wu,&nbsp;Yanbo Liu,&nbsp;Zhixiao Li,&nbsp;Yifan Jia,&nbsp;Hongbing Xiang","doi":"10.1002/mco2.70130","DOIUrl":"https://doi.org/10.1002/mco2.70130","url":null,"abstract":"<p>Sleep disorder significantly disrupts the quality of life for patients. Although it is clinically acknowledged, the fundamental neuropathological mechanisms are still not understood. Recent preclinical research has been directed toward understanding the fundamental mechanisms underlying the sleep deprivation and sleep/wake dysregulation. Sleep disorder is linked to changes in the structure and function of the neural basis of cognition. We reviewed the neural circuits related to sleep disorders, along with alterations in connectivity and brain region functions, based on advancements in electrophysiology and optogenetic/chemogenetic techniques. We subsequently outline the cellular and molecular modifications linked to sleep disorders in preclinical studies, primarily involving changes in neuronal metabolism, electrophysiological activity, synaptic plasticity, and glial cells. Correspondingly, on the basis of the crosstalk between the brain and peripheral organs, we elucidate the underlying mechanisms of the involvement of celiac disease and hepatic disease in the pathogenesis of sleep disorders. In this review, we mainly discussed the pathogenesis at molecular, cellular, and neural circuit levels that contribute to sleep disorder. The review also covered potential strategies for treating sleep disorders and future research avenues.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70130","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fusobacterium nucleatum Promotes the Growth and Metastasis of Colorectal Cancer by Activating E-Cadherin/Krüppel-Like Factor 4/Integrin α5 Signaling in a Calcium-Dependent Manner
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70137
Xuebing Yan, Xiao Qu, Jiaxin Wang, Ling Lu, Wenjuan Wu, Jingxian Mao, Donglin Li, Ying Wang, Qing Wei, Jianqiang Liu
{"title":"Fusobacterium nucleatum Promotes the Growth and Metastasis of Colorectal Cancer by Activating E-Cadherin/Krüppel-Like Factor 4/Integrin α5 Signaling in a Calcium-Dependent Manner","authors":"Xuebing Yan,&nbsp;Xiao Qu,&nbsp;Jiaxin Wang,&nbsp;Ling Lu,&nbsp;Wenjuan Wu,&nbsp;Jingxian Mao,&nbsp;Donglin Li,&nbsp;Ying Wang,&nbsp;Qing Wei,&nbsp;Jianqiang Liu","doi":"10.1002/mco2.70137","DOIUrl":"https://doi.org/10.1002/mco2.70137","url":null,"abstract":"<p>Gut microbiota and integrins are known to contribute to colorectal cancer (CRC), but whether they interact has been unclear. Here, we provided evidence that <i>Fusobacterium nucleatum</i> upregulated integrin α5 (ITGA5) in CRC in both human patients and murine models. Knocking down <i>ITGA5</i> in CRC cells weakened the ability of <i>F. nucleatum</i> to stimulate their malignant characteristics. <i>Fusobacterium nucleatum</i> increased intracellular Ca<sup>2+</sup> concentration, which in turn promoted interaction between E-cadherin and Krüppel-like factor 4 (KLF4), resulting in KLF4 phosphorylation and translocation in the nucleus, where it induced <i>ITGA5</i> transcription and activated the downstream signaling. Knocking down E-cadherin or chelating Ca<sup>2+</sup> with BAPTA-AM antagonized the impact of <i>F. nucleatum</i> on KLF4, whereas knocking down <i>KLF4</i> or chelating Ca<sup>2+</sup> antagonized the bacteria's oncogenic role. Knocking down <i>KLF4</i> or <i>ITGA5</i> attenuated <i>F. nucleatum–</i>induced growth of patient-derived organoids, subcutaneous xenografts, and orthotopic tumors, as well as liver metastasis in nude mice. Integrin α5 antibody antagonized the oncogenic role of <i>F. nucleatum</i> in vitro and in vivo. These findings suggest that <i>F. nucleatum</i> promotes the growth and metastasis of CRC by activating E-cadherin/KLF4/integrin α5 signaling in a Ca<sup>2+</sup>-dependent manner.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70137","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Utility of 18Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With 18Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
IF 10.7
MedComm Pub Date : 2025-03-10 DOI: 10.1002/mco2.70136
Lili Lin, Guangfa Wang, Yafei Zhang, Guolin Wang, Kui Zhao, Xinhui Su
{"title":"Clinical Utility of 18Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With 18Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography","authors":"Lili Lin,&nbsp;Guangfa Wang,&nbsp;Yafei Zhang,&nbsp;Guolin Wang,&nbsp;Kui Zhao,&nbsp;Xinhui Su","doi":"10.1002/mco2.70136","DOIUrl":"https://doi.org/10.1002/mco2.70136","url":null,"abstract":"<p>Pancreatic ductal adenocarcinoma (PDAC) is highly susceptible to metastasis, making early detection of metastases and associated risk factors crucial for effective management. This study aimed to assess the performance of <sup>18</sup>fluorine (<sup>18</sup>F)- fibroblast activation protein inhibitor-04 (<sup>18</sup>F-FAPI-04) positron emission tomography/computed tomography (PET/CT) in detecting metastasis and predicting pathological characteristics and risk factors in 67 PDAC patients. Comparisons were made with <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) PET/CT. Lesion identifications and radiotracer uptakes were evaluated through visual inspection and semiquantitative analysis using the maximum standardized uptake value (SUVmax). We analyzed the risk factors for metastasis and observed that <sup>18</sup>F-FAPI-04 identified more positive lesions and showed significantly higher SUVmax values than <sup>18</sup>F-FDG in both primary tumors and metastases, leading to upstaging in several cases. In primary tumors, <sup>18</sup>F-FAPI-04 was associated with higher levels of poorly differentiated PDAC, compared to those with moderately differentiated tumors. Notably, the SUVmax of 18F-FAPI-04 in primary tumors demonstrated a significant correlation with pathological differentiation and served as an independent prognostic factor for peritoneal metastasis, rather than lymph node or liver metastasis. Our findings suggested that <sup>18</sup>F-FAPI-04 PET/CT offers superior tumor detectability and improved node-metastasis (NM) staging in PDAC patients, positioning it as a more effective tool than <sup>18</sup>F-FDG PET/CT.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70136","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
IF 10.7
MedComm Pub Date : 2025-03-08 DOI: 10.1002/mco2.70121
Huimin Yuan, Ruochen Xu, Senlin Li, Mengzhu Zheng, Qingyi Tong, Ming Xiang, Yonghui Zhang
{"title":"The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions","authors":"Huimin Yuan,&nbsp;Ruochen Xu,&nbsp;Senlin Li,&nbsp;Mengzhu Zheng,&nbsp;Qingyi Tong,&nbsp;Ming Xiang,&nbsp;Yonghui Zhang","doi":"10.1002/mco2.70121","DOIUrl":"https://doi.org/10.1002/mco2.70121","url":null,"abstract":"<p>Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality globally, predominantly associated with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These infections drive persistent liver inflammation, culminating in cellular dysregulation, fibrosis, and cancer. Despite advancements in targeted therapies, drug resistance and the lack of reliable biomarkers for patient stratification still terribly hinder the treatment of viral HCC. To this end, the review delves into the intricate mechanisms underlying the malignant transformation of viral hepatitis to HCC, including viral integration, genomic instability, epigenetic modifications, oxidative stress, gut microbiota dysbiosis, chronic inflammation, immune escape, and abnormal signaling pathways, highlighting their complex interactions and synergies. Cutting-edge preclinical and clinical advancements in HCC management, including lifestyle modifications, drug therapies, immunotherapies, gene-based approaches, and innovative treatments, are further investigated, with particular priority given to their therapeutic potential and future applications in overcoming current limitations. By synthesizing recent scientific and clinical insights, this review aims to deepen the understanding of HCC pathogenesis in the context of chronic viral hepatitis, paving the way for novel therapeutic targets and personalized treatment strategies, ultimately improving patient outcomes.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70121","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143581752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases
IF 10.7
MedComm Pub Date : 2025-03-06 DOI: 10.1002/mco2.70101
Liuting Zeng, Wang Xiang, Wei Xiao, Yang Wu, Lingyun Sun
{"title":"The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases","authors":"Liuting Zeng,&nbsp;Wang Xiang,&nbsp;Wei Xiao,&nbsp;Yang Wu,&nbsp;Lingyun Sun","doi":"10.1002/mco2.70101","DOIUrl":"https://doi.org/10.1002/mco2.70101","url":null,"abstract":"<p>Neutrophil extracellular traps (NETs) are unique fibrous structures released by neutrophils in response to various pathogens, exhibiting both anti-inflammatory and proinflammatory effects. In autoimmune conditions, NETs serve as crucial self-antigens triggering inflammatory cascades by activating the inflammasome and complement systems, disrupting self-tolerance mechanisms and accelerating autoimmune responses. Furthermore, NETs play a pivotal role in modulating immune cell activation, affecting adaptive immune responses. This review outlines the intricate relationship between NETs and various diseases, including inflammatory arthritis, systemic autoimmune diseases, Behçet's disease, systemic lupus erythematosus, autoimmune kidney diseases, autoimmune skin conditions, systemic sclerosis, systemic vasculitis, and gouty arthritis. It highlights the potential of targeting NETs as a therapeutic strategy in autoimmune diseases. By examining the dynamic balance between NET formation and clearance in autoimmune conditions, this review offers critical insights and a theoretical foundation for future research on NET-related mechanisms. Advances in systems biology, flow cytometry, and single-cell multiomics sequencing have provided valuable tools for exploring the molecular mechanisms of neutrophils and NETs. These advancements have renewed focus on the role of neutrophils and NETs in autoimmune diseases, offering promising avenues for further investigation into their clinical implications.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143564992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信